Concerning the Thermal Diastereomerization
167
performed using standard pulse sequences as provided by the manufacturer. Typical 90ꢃ hard pulse
durations were 8.2 ꢀs (1H) and 16.6ꢀs (13C), 90ꢃ pulses in decoupling experiments were set to 67ꢀs.
HSQC and HMBC experiments were optimized for coupling constants of 145 Hz for single quantum
correlations and 10Hz for multi-bond correlations. The NOESY mixing time was set to 400 ms. Mass
spectra were recorded on a Hewlett Packard 5989 quadrupole instrument.
(Z)-1-Ethyl-4-(4-hydroxybenzylidene)-2-methyl-1H-imidazol-5(4H)-one ((Z)-1, C13H14N2O2)
To a solution of 0.3g 3 (1.2mmol) dissolved in 15cm3 EtOH containing 0.3g K2CO3 (2.2mmol),
0.15cm3 C2H5NH2 (70% in H2O) (1.9mmol) were added and the resulting mixture was heated to
reflux for 4 h. After cooling the K2CO3 was filtered off, the solution was concentrated in vacuo, and the
crude product was purified by silica gel chromatography using CHCl3=MeOH (10=1, v=v) as the
developing solvent to give 84 mg (Z)-1 (30% yield). TLC: Rf ¼ 0.6 (CHCl3:MeOH¼ 10:1); 1H
NMR (500 MHz, MeOD-d3, 30ꢃC): ꢁ ¼ 1.23 (t, J ¼ 7.14 Hz, –CH2–CH3), 2.38 (s, –CH3), 3.68 (q,
J ¼ 7.14Hz, –CH2–), 6.84 (d, J ¼ 8.51 Hz, –H30), 7.00 (s, –CH), 8.00 (d, J ¼ 8.51Hz, –H20) ppm;
NOESY (MeOD-d3): –H20 ! –CH and –H30, –H30 ! –H20, –CH2– ! –CH2–CH3, –CH2–CH3 !
13
–CH2–; C NMR (125 MHz, MeOD-d3, 30ꢃC): ꢁ ¼ 14.6 (–CH2–CH3), 15.3 (–CH3), 36.4 (–CH2–),
116.8 (C30), 126.9 (–CH), 129.2 (C10), 135.6 (C20), 137.1 (C4), 161.5 (C40), 163.0 (C2), 172.2 (C5)
ppm; HMBC (MeOD-d3): CH2–CH3 ! C2, C5, and –CH2–, –CH3 ! C2, C10 (weak), and C4 (weak),
–CH2– ! C5, C2, and –CH2–CH3, H30 ! C40, C20, –CH, and C30, –CH ! C5, C20, and C30 (weak),
H20 ! C40, C20, C10, –CH, and C30; HSQC data were according to structure; ESI-MS (MeOHþ 1 vol-
% HCOOH, ꢂ ꢄ 1 mgcmꢂ3, positive ion mode): m=z ¼ 231 ([M ꢂ H]þ).
(E)-1-Ethyl-4-(4-hydroxybenzylidene)-2-methyl-1H-imidazol-5(4H)-one ((E)-1, C13H14N2O2)
1H NMR (200 MHz, MeOD-d3, 30ꢃC): ꢁ ¼ 1.24 (t, J ¼ 7.14 Hz, –CH2–CH3), 2.35 (s, –CH3), 3.68 (q,
J ¼ 7.14Hz, –CH2–), 6.84 (d, J ¼ 8.56 Hz, –H30), 7.15 (s, –CH), 8.25 (d, J ¼ 8.56Hz, –H20) ppm.
(Z)-1-Ethyl-4-(4-methylbenzylidene)-2-methyl-1H-imidazol-5(4H)-one ((Z)-2, C14H16N2O)
Compound (Z)-2 was prepared from 4 according to (Z)-1 in 15% yield. 1H NMR (500MHz, MeOD-d3,
30ꢃC): ꢁ ¼ 1.33 (t, J ¼ 7.14Hz, –CH2–CH3), 2.11 (s, –CH3), 2.36 (s, ar–CH3), 4.26 (q, J ¼ 7.14 Hz,
–CH2–), 7.23 (d, J ¼ 7.41 Hz, –H30), 7.39 (s, –CH), 7.49 (d, J ¼ 7.41Hz, –H20) ppm; NOESY
(MeOD-d3): –H30 ! ar–CH3 and –H20, –CH2– ! –CH2–CH3; 13C NMR (125MHz, MeOD-d3,
30ꢃC): ꢁ ¼ 14.5 (–CH2–CH3), 21.4 (ar–CH3), 22.4 (–CH3), 62.5 (–CH2–), 126.1 (C4), 130.4 (C30),
131.0 (C20), 132.0 (C10), 135.4 (–CH), 141.3 (C40), 166.8 (C5), 173.2 (C2) ppm; HMBC (MeOD-d3):
CH3 ! C2, ar–CH3 ! C40 and C30, H30 ! C40, C10, and –CH, –CH ! C5 and C20, H20 ! C40, –CH,
C30, and C10 (weak); HSQC data were according to structure; ESI-MS (MeOH þ 1 vol-% HCOOH,
ꢂ ꢄ 1 mg cmꢂ3, positive ion mode): m=z ¼ 229 ([M ꢂ H] þ). This diastereomer proved to be config-
urationally stable in H2O solution up to 100ꢃC.
(E)-1-Ethyl-4-(4-methylbenzylidene)-2-methyl-1H-imidazol-5(4H)-one ((E)-2, C14H16N2O)
1H NMR characterization was only possible for a mixture of the (Z)-2:(E)-2 diastereomers (ratio 3:1),
which resulted in a few overlaps, in particular in the aromatic region. 1H NMR (500 MHz, MeOD-d3,
30ꢃC): ꢁ ¼ 1.51 (t, J ¼ 7.14Hz, –CH2–CH3), 2.05 (s, –CH3), 2.33 (s, ar–CH3), 4.15 (q, J ¼ 7.14 Hz,
–CH2–), 7.05–7.30 (m, 5H, no exact assignment possible due to an overlap with the signals of (Z)-2)
ppm. This diastereomer proved to be configurationally stable in H2O solution up to 100ꢃC, but reverted
partially to (Z)-2 under this condition.
(Z)-4-(4-Acetoxybenzylidene)-2-methyloxazol-5(4H)-one (3, C13H11NO4)
N-Acetylglycine, 4.6g (40 mmol), 5.6 g 4-hydroxybenzaldehyde (46 mmol), and 2.6 g anhydrous
CH3COONa (30 mmol) were added to 20cm3 (CH3CO)2O and the resulting mixture was heated to
reflux for 2 h. The solution was cooled with ice and then poured into 100 cm3 ice-H2O. The precipitate